Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders
Clinical trial NCT07443228 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07443228
- Sponsor
- Jecho Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2029-12-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.